Search research articles
Contact Us
Filters
Showing results (181-190 of 245) with videos related to
Page
of 25
Sort By:
Blood
|
October 29, 2005
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission
John M Pagel, Frederick R Appelbaum, Janet F Eary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission
Raya Mawad, Ted A Gooley, Vicky Sandhu, et al.
Leukemia & Lymphoma
|
April 9, 2014
Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity
Colin Phipps, Ajay K Gopal, Barry E Storer, et al.
Blood Advances
|
December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Gareth P Gregory, Shaji Kumar, Ding Wang, et al.
Hematological Oncology
|
September 20, 2014
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status
Maika Onishi, Solomon A Graf, Leona Holmberg, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2020
The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
Michael M Boyiadzis, Ivan Aksentijevich, Daniel A Arber, et al.
Blood
|
November 19, 2015
Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment
Johnnie J Orozco, Aimee Kenoyer, Ethan R Balkin, et al.
Haematologica
|
October 15, 2020
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration
Deborah M Stephens, Ken Boucher, Elizabeth Kander, et al.
Cancer Research
|
December 28, 2013
A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies
Damian J Green, Nural N Orgun, Jon C Jones, et al.
Blood
|
June 20, 2020
Use of convalescent plasma in hospitalized patients with COVID-19: case series
Livia Hegerova, Ted A Gooley, Kelly A Sweerus, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 245) with videos related to
Sort By:
Page
of 25
Blood
|
October 29, 2005
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission
John M Pagel, Frederick R Appelbaum, Janet F Eary, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission
Raya Mawad, Ted A Gooley, Vicky Sandhu, et al.
Leukemia & Lymphoma
|
April 9, 2014
Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity
Colin Phipps, Ajay K Gopal, Barry E Storer, et al.
Blood Advances
|
December 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Gareth P Gregory, Shaji Kumar, Ding Wang, et al.
Hematological Oncology
|
September 20, 2014
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status
Maika Onishi, Solomon A Graf, Leona Holmberg, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2020
The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
Michael M Boyiadzis, Ivan Aksentijevich, Daniel A Arber, et al.
Blood
|
November 19, 2015
Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment
Johnnie J Orozco, Aimee Kenoyer, Ethan R Balkin, et al.
Haematologica
|
October 15, 2020
Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration
Deborah M Stephens, Ken Boucher, Elizabeth Kander, et al.
Cancer Research
|
December 28, 2013
A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies
Damian J Green, Nural N Orgun, Jon C Jones, et al.
Blood
|
June 20, 2020
Use of convalescent plasma in hospitalized patients with COVID-19: case series
Livia Hegerova, Ted A Gooley, Kelly A Sweerus, et al.
Page
of 25